MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
for Pancreatic Ductal Adenocarcinoma
25 locations incl. Duarte
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06586515·Phase 1·Recruiting·Listed Sep 2024
Sarah Cannon Research Institute at HealthOne
Clinical research site in Denver, Colorado
Part of Sarah Cannon Research Institute
As of July 2026, 29 paid clinical trials are recruiting at Sarah Cannon Research Institute at HealthOne in Denver, Colorado. Active studies at this site cover conditions such as Advanced Solid Tumor and Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Sarah Cannon Research Institute at HealthOne (29)
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
for Advanced Cancer
37 locations incl. Birmingham
Sponsor: Artios Pharma Ltd
Sex: All·Age: 18+
Code: NCT04657068·Phase 1, Phase 2·Recruiting·Listed Dec 2020
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for Esophageal Squamous Cell Carcinoma
15 locations incl. Denver
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07503808·Phase 1·Recruiting·Listed Mar 2026
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
for Small-cell Lung Cancer
13 locations incl. Denver
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07174583·Phase 1, Phase 2·Recruiting·Listed Sep 2025
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
for HR+ Breast Cancer
18 locations incl. Duarte
Sponsor: NiKang Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07029399·Phase 1·Recruiting·Listed Jun 2025
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for Metastatic Solid Tumor
17 locations incl. Duarte
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06465069·Phase 1·Recruiting·Listed Jun 2024
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for Solid Tumors With HRAS Alterations
22 locations incl. Phoenix
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06026410·Phase 1·Recruiting·Listed Sep 2023
Study of HLD-0915 in Patients With Metastatic Prostate Cancer
for Metastatic Prostate Cancer
11 locations incl. Denver
Sponsor: Halda Therapeutics OpCo, Inc.
Sex: Male·Age: 18+
Code: NCT06800313·Phase 1, Phase 2·Recruiting·Listed Jan 2025
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for Small Cell Lung Cancer (SCLC)
15 locations incl. Duarte
Sponsor: Phanes Therapeutics
Sex: All·Age: 18+
Code: NCT05652686·Phase 1, Phase 2·Recruiting·Listed Dec 2022
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
for Advanced Solid Tumor
3 locations incl. Denver
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT04145622·Phase 1, Phase 2·Recruiting·Listed Oct 2019
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for Solid Tumor
11 locations incl. La Jolla
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT06619587·Phase 1·Recruiting·Listed Oct 2024
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
for Advanced Solid Tumor
13 locations incl. Phoenix
Sponsor: Nuvectis Pharma, Inc.
Sex: All·Age: 18+
Code: NCT05873686·Phase 1·Recruiting·Listed May 2023
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for Metastatic Solid Tumor
16 locations incl. Santa Monica
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06561685·Phase 1·Recruiting·Listed Aug 2024
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for Solid Tumor Malignancies
13 locations incl. Denver
Sponsor: Tasca Therapeutics
Sex: All·Age: 18+
Code: NCT07030257·Phase 1, Phase 2·Recruiting·Listed Jun 2025
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
for Locally Advanced Solid Tumor
17 locations incl. Irvine
Sponsor: Nuvalent Inc.
Sex: All·Age: 18+
Code: NCT06521554·Phase 1·Recruiting·Listed Jul 2024
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for Solid Tumor, Adult
9 locations incl. Denver
Sponsor: Kumquat Biosciences Inc.
Sex: All·Age: 18+
Code: NCT06507306·Phase 1·Recruiting·Listed Jul 2024
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
for Ovarian Cancer
14 locations incl. Denver
Sponsor: OnCusp Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06234423·Phase 1·Recruiting·Listed Jan 2024
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
for Advanced Solid Tumor
10 locations incl. Encinitas
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06108050·Phase 1·Recruiting·Listed Oct 2023
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
18 locations incl. Loma Linda
Sponsor: Marengo Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05592626·Phase 1, Phase 2·Recruiting·Listed Oct 2022
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
for Non-Small-Cell Lung
4 locations incl. Denver
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07519655·Phase 1·Recruiting·Listed Apr 2026
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
for Ovarian Cancer
5 locations incl. Denver
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07278336·Phase 1·Recruiting·Listed Dec 2025
First In Human Study of CX-2051 in Advanced Solid Tumors
for Solid Tumor, Adult
8 locations incl. Denver
Sponsor: CytomX Therapeutics
Sex: All·Age: 18+
Code: NCT06265688·Phase 1·Recruiting·Listed Feb 2024
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for Advanced Solid Tumor
7 locations incl. Tucson
Sponsor: Vaxiion Therapeutics
Sex: All·Age: 18+
Code: NCT05901285·Phase 1·Recruiting·Listed Jun 2023
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
for Locally Advanced/Metastatic Solid Tumors
5 locations incl. Denver
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All·Age: 18+
Code: NCT06414460·Phase 1, Phase 2·Recruiting·Listed May 2024
SMP-3124LP in Adults With Advanced Solid Tumors
for Solid Tumor
8 locations incl. Los Angeles
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 18+
Code: NCT06526819·Phase 1, Phase 2·Recruiting·Listed Jul 2024
Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
for Malignant Mesothelioma
6 locations incl. Denver
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All·Age: 18+
Code: NCT06566079·Phase 1·Recruiting·Listed Aug 2024
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
for Advanced Solid Tumors
6 locations incl. Denver
Sponsor: Eikon Therapeutics
Sex: All·Age: 18 - 89
Code: NCT06907043·Phase 1, Phase 2·Recruiting·Listed Apr 2025
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
for Advanced Solid Tumor
5 locations incl. Duarte
Sponsor: ABL Bio, Inc.
Sex: All·Age: 18+
Code: NCT04762641·Phase 1·Recruiting·Listed Feb 2021
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
for Cancer
6 locations incl. Scottsdale
Sponsor: Simcha IL-18, Inc.
Sex: All·Age: 18+
Code: NCT04787042·Phase 1, Phase 2·Recruiting·Listed Mar 2021
More research sites in Denver
- Colorado Blood Cancer Institute (47 trials)
- National Jewish Health (43 trials)
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center (18 trials)
- Rocky Mountain Cancer Centers (17 trials)
- Kaiser Permanente-Franklin (15 trials)
- UCHealth - Cherry Creek (13 trials)
- University of Colorado (13 trials)
- Denver Health Medical Center (11 trials)
- Presbyterian - Saint Lukes Medical Center - Health One (10 trials)
- Rocky Mountain Cancer Centers-Midtown (10 trials)
Explore more
Paid clinical trials in Denver, CO · Colorado clinical trials